198 related articles for article (PubMed ID: 8618249)
21. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication.
Tobias JD; Gregory DF; Deshpande JK
Pediatr Emerg Care; 1992 Dec; 8(6):345-6. PubMed ID: 1360651
[TBL] [Abstract][Full Text] [Related]
22. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.
Bateman DN; Dear JW; Thanacoody HK; Thomas SH; Eddleston M; Sandilands EA; Coyle J; Cooper JG; Rodriguez A; Butcher I; Lewis SC; Vliegenthart AD; Veiraiah A; Webb DJ; Gray A
Lancet; 2014 Feb; 383(9918):697-704. PubMed ID: 24290406
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.
Nakagaki M; Barras M; Curley C; Butler JP; Kennedy GA
Support Care Cancer; 2017 Feb; 25(2):607-613. PubMed ID: 27738796
[TBL] [Abstract][Full Text] [Related]
24. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
Warden CR; Moreno R; Daya M
Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
[TBL] [Abstract][Full Text] [Related]
26. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Gebbia V; Testa A; Cannata G; Gebbia N
Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
[TBL] [Abstract][Full Text] [Related]
27. Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.
Eisenberg S; Wickline M; Linenberger M; Gooley T; Holmberg L
Oncol Nurs Forum; 2013 May; 40(3):285-92. PubMed ID: 23615140
[TBL] [Abstract][Full Text] [Related]
28. Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis.
Yarboro CH; Wesley R; Amantea MA; Klippel JH; Pucino F
Ann Pharmacother; 1996; 30(7-8):752-5. PubMed ID: 8826554
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of combination of ondansetron injection and tablet in CAF-induced emesis in breast cancer patients].
Shinohara H; Yonekawa H; Machimura T; Furukawa T; Nishihori H; Kurihara N; Urakami H; Nemoto Y
Gan To Kagaku Ryoho; 1998 Feb; 25(3):397-402. PubMed ID: 9492834
[TBL] [Abstract][Full Text] [Related]
31. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ
N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054
[TBL] [Abstract][Full Text] [Related]
32. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
33. Single-dose prophylaxis for postoperative nausea and vomiting after major abdominal surgery: ondansetron versus droperidol.
Paech MJ; Pavy TJ; Evans SF
Anaesth Intensive Care; 1995 Oct; 23(5):548-54. PubMed ID: 8787252
[TBL] [Abstract][Full Text] [Related]
34. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery.
Sun R; Klein KW; White PF
Anesth Analg; 1997 Feb; 84(2):331-6. PubMed ID: 9024023
[TBL] [Abstract][Full Text] [Related]
35. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
Navari RM; Madajewicz S; Anderson N; Tchekmedyian NS; Whaley W; Garewal H; Beck TM; Chang AY; Greenberg B; Caldwell KC
J Clin Oncol; 1995 Sep; 13(9):2408-16. PubMed ID: 7666101
[TBL] [Abstract][Full Text] [Related]
36. Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group.
Kovac AL; Pearman MH; Khalil SN; Scuderi PE; Joslyn AF; Prillaman BA; Cox F
J Clin Anesth; 1996 Dec; 8(8):644-51. PubMed ID: 8982892
[TBL] [Abstract][Full Text] [Related]
37. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
Korttila K; Clergue F; Leeser J; Feiss P; Olthoff D; Payeur-Michel C; Wessel P; Nave S; Hahne W; Brown R
Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937
[TBL] [Abstract][Full Text] [Related]
38. Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group.
Beck TM; York M; Chang A; Navari R; Harvey WH; Meshad M; Griffin D; Wentz A
Cancer Invest; 1997; 15(4):297-303. PubMed ID: 9246149
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).
Ades S; Halyard M; Wilson K; Ashikaga T; Heimann R; Kumar S; Blackstock W
Support Care Cancer; 2017 May; 25(5):1503-1510. PubMed ID: 28032216
[TBL] [Abstract][Full Text] [Related]
40. Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. The French Ondansetron Study Group.
Diemunsch P; Conseiller C; Clyti N; Mamet JP
Br J Anaesth; 1997 Sep; 79(3):322-6. PubMed ID: 9389849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
